NASDAQ · Biotechnology
Virax Biolabs Group Limited Ordinary Shares (VRAX)
$0.33
-12.89%
19
Oversold
Moving averages
SMA 200$3.66-90.93%
Company profile
Virax Biolabs Group Limited, a biotechnology company, sells, distributes and markets diagnostic test kits and medical technology products and PPE for the prevention, detection, diagnosis and risk management of viral diseases in the field of immunology. The company is headquartered in London, the United Kingdom.
SectorHealthcare
IndustryBiotechnology
Market cap$843,440
P/E ratioNone
EPS$-12.64
Beta1.481
Dividend yield0.00%
52-week high$21.75
52-week low$0.50
Similar stocks in Biotechnology
BNTX
BioNTech SE
RSI 32
VRTX
Vertex Pharmaceuticals Inc
RSI 43
CRSP
CRISPR Therapeutics AG
RSI 27
IOVA
Iovance Biotherapeutics Inc
RSI 31
ARTL
Artelo Biosciences Inc
RSI 26
ZVSA
ZyVersa Therapeutics Inc
RSI 16
IMNN
Imunon Inc
RSI 25
ACXP
Acurx Pharmaceuticals Inc
RSI 45
SKYE
Skye Bioscience Inc
RSI 32
SNGX
Soligenix Inc
RSI 21
RSI alerts for VRAX
An email when VRAX closes below RSI 30 or above 70. Nothing else.
Data last updated 13 November 2026 at 4:25 AM EST